awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28553482-364BB782-9BF5-4880-903D-3984227EE5DD
Q28553482-364BB782-9BF5-4880-903D-3984227EE5DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28553482-364BB782-9BF5-4880-903D-3984227EE5DD
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
P2860
Q28553482-364BB782-9BF5-4880-903D-3984227EE5DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28553482-364BB782-9BF5-4880-903D-3984227EE5DD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da9837f214051642121e69908e7c33251f80b578
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.